Somaiya Vidyavihar University, a prestigious educational institution, has announced the International Conference on Clinical Translation of Biomaterial-based Therapeutics and Devices (ICBTD 2025). The event, scheduled for 6–7 February 2025, will bring together renowned global experts to discuss pioneering advances in biomaterials and their clinical applications.
Endorsed by the Society of Biomaterials and Artificial Organs, India (SBAOI), and organised in collaboration with Somaiya's Internal Quality Assurance Cell (IQAC), ICBTD 2025 aims to accelerate progress in the clinical translation of biomaterials.
The conference will delve into critical topics, including:
- Advances in biomaterials for tissue regeneration, drug delivery, and diagnostics.
- Challenges in clinical translation, including navigating regulatory processes and overcoming technological hurdles.
- Regulatory guidelines and ethical considerations in biomedical research.
ICBTD 2025 will feature discussions, lectures, and presentations by leading researchers, industry pioneers, and regulatory experts (names to be added), who will share their insights into the latest innovations in biomaterials. A key highlight of the event will be a panel discussion on the challenges of translating medical technologies into clinical use, bringing together experts from clinical, industrial, regulatory, and research sectors.
Chancellor Shri Samir Somaiya emphasised the university's commitment to fostering global collaboration, stating, "This conference exemplifies our vision of promoting global partnerships in biomedical sciences. By bridging research with real-world applications, we aim to ensure that biomaterial innovations benefit society at large."
Dr. V. N. Rajasekharan Pillai, Vice-Chancellor of Somaiya Vidyavihar University, added, "It is an honour to host the International Conference on Biomaterials, where brilliant minds unite to shape the future of healthcare. This platform fosters collaboration, explores cutting-edge advancements in biomaterial science, and addresses the challenges of translating research into real-world applications. Together, we can unlock the full potential of biomaterials and transform healthcare for generations to come."